Cargando…

The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines

The major cause of ovarian cancer treatment failure in cancer patients is inherent or acquired during treatment drug resistance of cancer. Matrix Gla protein (MGP) is a secreted, non-collagenous extracellular matrix protein involved in inhibition of tissue calcification. Recently, MGP expression was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sterzyńska, Karolina, Klejewski, Andrzej, Wojtowicz, Karolina, Świerczewska, Monika, Andrzejewska, Małgorzata, Rusek, Damian, Sobkowski, Maciej, Kędzia, Witold, Brązert, Jacek, Nowicki, Michał, Januchowski, Radosław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213242/ https://www.ncbi.nlm.nih.gov/pubmed/30257426 http://dx.doi.org/10.3390/ijms19102901

Ejemplares similares

Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines
por: Sterzyńska, Karolina, et al.
Publicado: (2018)

Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development
por: Sterzyńska, Karolina, et al.
Publicado: (2018)

New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines
por: Świerczewska, Monika, et al.
Publicado: (2017)

The significance of lumican expression in ovarian cancer drug-resistant cell lines
por: Klejewski, Andrzej, et al.
Publicado: (2017)

Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines
por: Sterzyńska, Karolina, et al.
Publicado: (2019)

Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model
por: Nowacka, Marta, et al.
Publicado: (2022)

Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines
por: Januchowski, Radosław, et al.
Publicado: (2016)

Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs
por: Wojtowicz, Karolina, et al.
Publicado: (2021)

New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines
por: Świerczewska, Monika, et al.
Publicado: (2018)

Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
por: Januchowski, Radosław, et al.
Publicado: (2016)

Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines
por: Januchowski, Radosław, et al.
Publicado: (2017)

PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations
por: Świerczewska, Monika, et al.
Publicado: (2019)

The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines
por: Kazmierczak, Dominika, et al.
Publicado: (2022)

MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines
por: Januchowski, Radosław, et al.
Publicado: (2013)

Association of Genetic Polymorphisms in the Matrix Gla Protein (MGP) Gene with Coronary Artery Disease and Serum MGP Levels
por: Karsli-Ceppioglu, S, et al.
Publicado: (2019)

Generation of a Matrix Gla (Mgp) floxed mouse, followed by conditional knockout, uncovers a new Mgp function in the eye
por: Borrás, Teresa, et al.
Publicado: (2020)

Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma
por: Mertsch, Sonja, et al.
Publicado: (2009)

Expression analysis of the osteoarthritis genetic susceptibility mapping to the matrix Gla protein gene MGP
por: Shepherd, Colin, et al.
Publicado: (2019)

The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines
por: Kazmierczak, Dominika, et al.
Publicado: (2020)

The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines
por: Stasiak, Piotr, et al.
Publicado: (2022)

Matrix Gla-Protein (MGP) Not Only Inhibits Calcification in Large Arteries But Also May Be Renoprotective: Connecting the Dots
por: Epstein, Murray
Publicado: (2016)

Plasma dephosphorylated-uncarboxylated Matrix Gla-Protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential
por: Griffin, Tomás Patrick, et al.
Publicado: (2019)

Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin
por: Du, Tian, et al.
Publicado: (2022)

Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan.
por: Vukovic, V., et al.
Publicado: (1997)

Polymorphisms in MGP gene and their association with lead toxicity
por: Shaik, Abjal Pasha, et al.
Publicado: (2009)

Dp-ucMGP as a Biomarker in Sarcopenia
por: Schweighofer, Natascha, et al.
Publicado: (2022)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line
por: Januchowski, Radosław, et al.
Publicado: (2014)

Sequence variation and immunogenicity of the Mycoplasma genitalium MgpB and MgpC adherence proteins during persistent infection of men with non-gonococcal urethritis
por: Wood, Gwendolyn E., et al.
Publicado: (2020)

CNN-MGP: Convolutional Neural Networks for Metagenomics Gene Prediction
por: Al-Ajlan, Amani, et al.
Publicado: (2018)

No association between MGP rs1800802 polymorphism and stenosis of the coronary artery
por: Roustazadeh, Abazar, et al.
Publicado: (2013)

The Role of GRP and MGP in the Development of Non-Hemorrhagic VKCFD1 Phenotypes
por: Ghosh, Suvoshree, et al.
Publicado: (2022)

The Active Isoforms of MGP Are Expressed in Healthy and Varicose Veins without Calcification
por: Gheorghe, Simona R., et al.
Publicado: (2021)

MGP-AttTCN: An interpretable machine learning model for the prediction of sepsis
por: Rosnati, Margherita, et al.
Publicado: (2021)

A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer
por: Guppy, A E, et al.
Publicado: (2004)

Evolution of Matrix Gla and Bone Gla Protein Genes in Jawed Vertebrates
por: Leurs, Nicolas, et al.
Publicado: (2021)

A Naturally Fluorescent Mgp Transgenic Mouse for Angiogenesis and Glaucoma Longitudinal Studies
por: Asokan, Priyadarsini, et al.
Publicado: (2018)

SNP haplotyping technique for evaluation of MGP 5′ UTR power in osteoblast cells
por: Roustazadeh, Abazar, et al.
Publicado: (2016)

Commentary: Periocular topotecan for retinoblastoma
por: Sharma, Minal, et al.
Publicado: (2018)

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7orb699ghe37nnrms9gftlf0pp